Vantari Genetics, Irvine, Calif, and Translational Software Inc (TSI), Bellevue, Wash, have partnered to provide genotype testing, actionable genomic information, and custom reporting in support of the GeneMatch registry at Banner Alzheimer’s Institute (BAI). The GeneMatch registry is a national program that leverages genetic testing information to recruit participants for Alzheimer’s prevention studies.
Researchers have identified a number of genes associated with Alzheimer’s disease. The most common form of the disease is called late-onset Alzheimer’s, which usually begins after age 65 and is associated with a gene called apolipoprotein E (APOE).
Vantari Genetics and TSI are collaborating to support the GeneMatch program through APOE testing and interpreting the cheek swabs of volunteers interested in participating in community-based Alzheimer’s research opportunities. The raw genomic and molecular data from the tests are analyzed to provide scientific intelligence about the genetic variants of volunteers, which is used to identify study participants at varying degrees of genetic risk for developing Alzheimer’s disease, and to match them to available research studies.